In an era of highly active antiretroviral therapy(HAART), liver transplantation is becoming an effective therapy inHIV patients suffering from hepatitis C virus (HCV)/hepatitis B virus(HBV) cirrhosis.1 The increase in survival of patients with HIV infection,attributed to HAART, has prompted the medical community toconsider therapeutic strategies including the possibility of major surgeryand solid organ transplantation to contrast the clinical picture ofend organ failure.In this clinical setting, several studies have consistently associatedan increased risk of death as a result of hepatocellular carcinoma(HCC) with HIV infection.2 In a large French survey, HCC-relateddeath in HIV patients rose from 11% in 1997 to 25% in 2001.3 Moreover,some reports have emphasized a more aggressive course ofHCCwith respect to HCC seen in HIV-negative individuals.4,5 In particular,the HCC is diagnosed at a younger age, and is generally more advanced(infiltrating ormetastatic) at diagnosis.6 Recent evidences suggesta crucial role of the HIV TAT protein to drive hepatocarcinogenesis inpatients with virus- or alcohol-mediated cirrhosis7,8; a coexistent weakerantitumor response because of a chronically low CD4 and CD8 lymphocytecounts must also be kept in due consideration. Consequently, amorefrequentscreeningthanevery6monthshasbeenwarrantedbecauseof the swifter course of HCC

Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era / Benedetto, F. D.; Ruvo, N. D.; Berretta, M.; Masetti, M.; Montalti, R.; Di Sandro, Stefano; Quintini, C.; Codeluppi, M.; Tirelli, U.; Gerunda, G. E.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 24:14(2006), pp. e26-e27. [10.1200/JCO.2006.06.1374]

Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era.

F. D. Benedetto;M. Masetti;Stefano Di Sandro;C. Quintini;G. E. Gerunda
2006

Abstract

In an era of highly active antiretroviral therapy(HAART), liver transplantation is becoming an effective therapy inHIV patients suffering from hepatitis C virus (HCV)/hepatitis B virus(HBV) cirrhosis.1 The increase in survival of patients with HIV infection,attributed to HAART, has prompted the medical community toconsider therapeutic strategies including the possibility of major surgeryand solid organ transplantation to contrast the clinical picture ofend organ failure.In this clinical setting, several studies have consistently associatedan increased risk of death as a result of hepatocellular carcinoma(HCC) with HIV infection.2 In a large French survey, HCC-relateddeath in HIV patients rose from 11% in 1997 to 25% in 2001.3 Moreover,some reports have emphasized a more aggressive course ofHCCwith respect to HCC seen in HIV-negative individuals.4,5 In particular,the HCC is diagnosed at a younger age, and is generally more advanced(infiltrating ormetastatic) at diagnosis.6 Recent evidences suggesta crucial role of the HIV TAT protein to drive hepatocarcinogenesis inpatients with virus- or alcohol-mediated cirrhosis7,8; a coexistent weakerantitumor response because of a chronically low CD4 and CD8 lymphocytecounts must also be kept in due consideration. Consequently, amorefrequentscreeningthanevery6monthshasbeenwarrantedbecauseof the swifter course of HCC
24
14
e26
e27
Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era / Benedetto, F. D.; Ruvo, N. D.; Berretta, M.; Masetti, M.; Montalti, R.; Di Sandro, Stefano; Quintini, C.; Codeluppi, M.; Tirelli, U.; Gerunda, G. E.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - STAMPA. - 24:14(2006), pp. e26-e27. [10.1200/JCO.2006.06.1374]
Benedetto, F. D.; Ruvo, N. D.; Berretta, M.; Masetti, M.; Montalti, R.; Di Sandro, Stefano; Quintini, C.; Codeluppi, M.; Tirelli, U.; Gerunda, G. E.
File in questo prodotto:
File Dimensione Formato  
Dont Deny_FDB.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 55.62 kB
Formato Adobe PDF
55.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/729247
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 48
  • ???jsp.display-item.citation.isi??? ND
social impact